BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 15769920)

  • 21. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E epsilon 4 in inclusion body myositis.
    Garlepp MJ; Tabarias H; van Bockxmeer FM; Zilko PJ; Laing B; Mastaglia FL
    Ann Neurol; 1995 Dec; 38(6):957-9. PubMed ID: 8526471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inclusion body myositis. Report of 4 cases].
    Basquiera AL; Caeiro F; Palacio S; Theaux R; Casale A; Lucero C; Alvarellos A
    Medicina (B Aires); 2002; 62(1):37-40. PubMed ID: 11965848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis.
    Girolamo F; Lia A; Amati A; Strippoli M; Coppola C; Virgintino D; Roncali L; Toscano A; Serlenga L; Trojano M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):736-49. PubMed ID: 23452291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary inclusion-body myopathy].
    Kucharz EJ
    Przegl Lek; 1999; 56(11):735-8. PubMed ID: 10800587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clinical and pathological analysis of inclusion body myositis].
    Hu J; Li N; Yuan JH; Zhao Z; Shen HR; Mei L
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):658-60. PubMed ID: 17967238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory, immune, and viral aspects of inclusion-body myositis.
    Dalakas MC
    Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
    Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
    Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology.
    Fidziańska A; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
    Acta Neuropathol; 2004 Mar; 107(3):197-203. PubMed ID: 14712398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inclusion body myositis associated with sacroidosis: a report of 3 cases].
    Bouillot S; Coquet M; Ferrer X; Lagueny A; Leroy JP; Vital C
    Ann Pathol; 2001 Aug; 21(4):334-6. PubMed ID: 11685131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of multiple mitochondrial DNA deletions in inclusion body myositis.
    Moslemi AR; Lindberg C; Oldfors A
    Hum Mutat; 1997; 10(5):381-6. PubMed ID: 9375854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.
    Brady S; Squier W; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy.
    Goebel HH; Halbig LE; Goldfarb L; Schober R; Albani M; Neuen-Jacob E; Voit T
    Neuropediatrics; 2001 Aug; 32(4):196-205. PubMed ID: 11571700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
    Greenberg SA; Pinkus JL; Amato AA
    Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased aging in primary muscle cultures of sporadic inclusion-body myositis.
    Morosetti R; Broccolini A; Sancricca C; Gliubizzi C; Gidaro T; Tonali PA; Ricci E; Mirabella M
    Neurobiol Aging; 2010 Jul; 31(7):1205-14. PubMed ID: 18823681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
    Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J
    Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis.
    Tasca G; Monforte M; De Fino C; Kley RA; Ricci E; Mirabella M
    Muscle Nerve; 2015 Dec; 52(6):956-62. PubMed ID: 25808807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled.
    van de Vlekkert J; Hoogendijk JE; de Visser M
    Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.